• Tidak ada hasil yang ditemukan

PKB XXVI 2018 Pendidikan Kedokteran Berkelanjutan (PKB) XXVI Ilmu Penyakit Dalam FK UNUD/RSUP Sanglah 2018

N/A
N/A
Protected

Academic year: 2021

Membagikan "PKB XXVI 2018 Pendidikan Kedokteran Berkelanjutan (PKB) XXVI Ilmu Penyakit Dalam FK UNUD/RSUP Sanglah 2018"

Copied!
25
0
0

Teks penuh

(1)
(2)

PKB XXVI 2018

Pendidikan Kedokteran Berkelanjutan (PKB) XXVI

Ilmu Penyakit Dalam FK UNUD/RSUP Sanglah 2018

“Controversies in Internal Medicine”

PROCEEDING BOOK

Prime Plaza Hotel-

Gedung Angsoka Lantai 4 RSUP Sanglah Denpasar

1-3 November 2018

EDITORS :

Prof. DR. dr. I Made Bakta, Sp.PD-KHOM, FINASIM

Prof. DR. dr. I Dewa Nyoman Wibawa, Sp.PD-KGEH, FINASIM

Prof. DR. dr. Ketut Suastika, SpPD-KEMD

Prof. DR. dr. Tjok Raka Putra, SpPD-KR

Prof. DR. dr. K Tuti Parwati, SpPD-KPTI

Prof. DR. dr. IB Ngurah Rai, SpP (K)

Prof. DR. dr. Gde Raka Widiana, SpPD-KGH

DR. dr. Tuty Kuswardani, SpPD-KGer, MARS

DR. dr. K Rina, SpPD, SpJP

(3)

i

KATA PENGANTAR

Ilmu Penyakit Dalam berkembang sangat cepat menuntut

klinisi untuk senantiasa memperbaharui keilmuan dan

keahliannya serta memiliki kualitas sesuai dengan standar

global untuk meningkatkan pelayanan medis. Informasi ilmu

pengetahuan dan teknologi kedokteran saat ini mudah

diakses oleh siapa saja, menciptakan masyarakat yang

semakin kritis dan tentunya memunculkan tantangan

tersendiri bagi klinisi.

Akses

komuniksi

memudahkan

dokter

mendapatkan

informasi terkini, namun akses forum ilmiah memberi

kesempatan untuk bertatap muka langsung dengan para ahli

sambil menjalin ikatan kekeluargaan.

Pendidikan Kedokteran Berkelanjutan (PKB) Ilmu Penyakit

Dalam FK UNUD/RSUP Sanglah adalah kegiatan ilmiah di

bidang Ilmu Penyakit Dalam yang diselenggarakan setiap

tahun sekali. Pada rangkaian kegiatan PKB XXVI Ilmu

Penyakit Dalam FK UNUD/RSUP Sanglah 2018 ini,

kontroversi manajemen penyakit di bidang Ilmu Penyakit

Dalam akan disajikan dalam bentuk pelatihan (workshop),

simposium, dan diskusi pakar sehingga kesempatan

interaksi peserta dan pakar menjadi optimal.

Denpasar, 2 Mei 2018

Ketua Panitia

(4)

ii

EDITOR

Prof. DR. dr. I Made Bakta, Sp.PD-KHOM, FINASIM

Prof. DR. dr. I Dewa Nyoman Wibawa, Sp.PD-KGEH, FINASIM

Prof. DR. dr. Ketut Suastika, SpPD-KEMD

Prof. DR. dr. Tjok Raka Putra, SpPD-KR

Prof. DR. dr. K Tuti Parwati, SpPD-KPTI

Prof. DR. dr. IB Ngurah Rai, SpP (K)

Prof. DR. dr. Gde Raka Widiana, SpPD-KGH

DR. dr. Tuty Kuswardani, SpPD-KGer, MARS

(5)

iii

SUSUNAN PANITIA

Panitia Pengarah

1. Ketua Bagian Ilmu Penyakit Dalam FK

Unud/RSUP Sanglah

2. Kepala-Kepala Divisi di Lingkungan Bagian

Ilmu Penyakit Dalam FK Unud/RSUP Sanglah

Ketua Pelaksana

Dr. dr. Made Ratna Saraswati, SpPD-KEMD

Wakil Ketua

dr. I Wayan Losen Adnyana, SpPD-KHOM

Sekretaris

dr. IGN Agung Tresna Erawan, SpPD

Bendahara

dr. Pande Ketut Kurniari, SpPD

dr. Ni Wayan Wina Dharmesti

PIC Kegiatan

dr. Kadek Wisnu Mataram

Seksi Kesekretariatan

dr. Gede Kambayana, SpPD-KR

dr. Gde Somayana, SpPD

dr. Dian Pritasari Jeger

dr. Trisna Yuliharti Tersinanda

dr. Amarisa Malik

dr. Prima Yogi

dr. Carissa Ayu Zebadiah

dr. Abigail

Seksi Acara

dr. Nyoman Paramita Ayu, SpPD

dr. Ary Wismayana

dr. Adi Suryana

dr. Anantika Riani

(6)

iv

dr. Imayati

dr. Gusti Ayu Sri Bidani

dr. Karlina Isabela

dr. Bayu Prawira

Seksi Ilmiah

Prof. DR. dr. I Made Bakta, SpPD-KHOM

Prof. DR. dr. Ketut Suastika, SpPD-KEMD

Prof. DR. dr. Tjok Raka Putra, SpPD-KR

Prof. DR. dr. I DN Wibawa, SpPD-KGEH

Prof. DR. dr. K Tuti Parwati, SpPD-KPTI

Prof. DR. dr. IB Ngurah Rai, SpP (K)

Prof. DR. dr. Gde Raka Widiana, SpPD-KGH

DR. dr. K Rina, SpPD, SpJP

DR. dr. Tuty Kuswardani, SpPD-KGer, MARS

DR. dr. Ketut Suega, SpPD-KHOM

DR. dr. Wayan Sudhana, SpPD-KGH

DR. dr. Yenny Kandarini, SpPD-KGH

dr. Nyoman Astika, SpPD-KGer

dr. IGP Suka Aryana, SpPD-KGer

dr. I Made Siswadi Semadi, SpPD

dr. I Putu Sistawidyautama

dr. Ngurah Arika Fermiawan

dr. I Gede Agus Aprianta

dr. Gilang Bhaskara

(7)

v

dr. I Komang Agus Wira Nugraha

dr. Kurniawan

Seksi Dana

Prof. DR. dr. K Suastika, SpPD-KEMD

Prof. DR. dr. I DN Wibawa, SpPD-KGEH

dr. Jodi S Loekman, SpPD-KGH

dr. I GA Suryadharma, SpPD-KGEH

DR. dr. Yenny Kandarini, SpPD-KGH

dr. Bayu Indratama

Seksi Perlengkapan

dr. Ketut Suardamana, SpPD-KAI

dr. I Ketut Mariadi, SpPD-KGEH

dr. IGP Hery Sikesa

dr. AAN Wistara Widya

dr. IGA Wilaja P

dr. Komang Realiska

dr. Kurniawan Adi Prabowo

dr. I Dewa Made Widya Sidharta

dr. Adrian Adinata Candra

dr. Eka Handrean

Seksi Pameran

dr. Nyoman Purwadi, SpPD-KGEH

dr. Made Pande Dwipayana, SpPD-KEMD

dr. Dewa Gede Teguh Krisna M

dr. Godfried EY Saragih

dr. Eko Radityo

(8)

vi

Seksi

Transportasi-Akomodasi

dr. Susila Utama, SpPD-KPTI

dr. Losen Adnyana, SpPD-KHOM

dr. Indra Adi Kusuma

dr. Made Suwarno

dr. Putu Oka Yudaswara Pande

dr. Arya Winangun

Seksi Registrasi

dr. Renny A. Rena, SpPD-KHOM

dr. Sajinadiyasa, SpPD

dr. Nadia

dr. Ni Wayan Ariani Vitriasari

dr. Juni Wulan

Seksi Konsumsi

dr. Tjok Istri Anom Saturti, SpPD

dr. IGA Ira Mahariani B

dr. Rose Vita Sari

dr. Ni Luh Putu Herawati

dr. Gusde Janardana

Seksi Kerohanian

dr. AAA Yuli Gayatri, SpPD

dr. Tjok Gde Darmayuda, SpPD-KHOM

dr. Putu Yuliani Widiasari

Seksi Humas

dan Publikasi

dr. Dewi Dian Sukmawati, SpPD

dr. Ni Ketut Rai Purnami, SpPD

dr. Aditya Saskara

(9)

vii

dr. Putu Pangestu Cendra Nata

Seksi Dokumentasi

dr. Putu Andrika, SpPD-KIC

dr. Reza Surahmanto

dr. Putu Shely

dr. Sandra

dr. Eko Radityo

Karyawan Sekretariat

Adi Swastika

Komang Rupawan

(10)

viii

DAFTAR ISI

KATA PENGANTAR

i

KONTRIBUTOR

ii

DAFTAR ISI

viii

JADWAL ACARA

xiv

MATERI

SYMPOSIUM

CONTROVERSIES IN MEDICINE: CHALLENGES AND

OPPORTUNITIES

I Made Bakta

1

GOAL ORIENTED IN HYPERTENSION: UNDER CONTROL

WITH SINGLE PILL COMBINATION: AMLODIPINE/

VALSARTAN

I Wayan Sudhana

11

CURRENT CONCEPTS IN CHRONIC HEPATITIS B

TREATMENT

I D N Wibawa

19

ANTIVIRAL THERAPY: SHOULD IT BE LIFELONG?

I G A Suryadharma

28

ROLE OF KIDNEY IN GLUCOSE HOMEOSTASIS

I Gde Raka Widiana

(11)

ix

LINKING TYPE 2 DIABETES MEDICATION WITH

CARDIOVASCULAR OUTCOME

Ketut Suastika

58

DIAGNOSTIC MODALITY FOR LUNG TUBERCULOSIS

I Made Bagiada

ROLE OF IGRA IN DIAGNOSIS OF LUNG TUBERCULOSIS

Elva Aprilia Nasution

72

88

CONTROVERSION OF PHARMACOLOGIC THERAPY FOR

ANOREXIA IN ELDERLY

Tuty Kuswardhani

89

CHOOSING AMINO ACIDS FOR TREATING SARCOPENIA

IN ELDERLY: WHICH ONE IS BETTER?

I G P Suka Aryana

106

OVERVIEW OF OSTOEOARTHRITIS

Tjokorda Raka Putra

113

CURRENT TREATMENT OF OSTEOARTHRITIS

Gde Kambayana

127

CORTICOSTEROID HARMFUL EFFECTS ON SEPSIS

I Ketut Agus Somia

136

MANAGEMENT OF DIABETES: START WITH THE RIGHT

CHOICE

I Ketut Suastika

142

MANAGEMENT OF HYPERTHYROIDISM

Made Ratna Saraswati

(12)

x

REPLACEMENT THERAPY IN HYPOTHYROIDISM

Risa Anwar

160

INSULIN THERAPY IN THE DIABETES EMERGENCY:

WHAT'S THE GUIDELINE SAID TO IMPROVE PATIENT

OUTCOME

Ketut Suastika

165

THE ROLE OF RAPID INSULIN ANALOGUE IN DIABETES

MANAGEMENT: FOCUS ON GLULISINE CLINICAL

EVIDENCE

Made Ratna Saraswati

177

MECHANISM OF DRUG ALLERGY

Ketut Suryana

184

DIAGNOSIS AND MANAGEMENT OF DRUG ALLERGY

Ketut Suardamana

194

CURRENT DIABETES ORAL TREATMENT: ARE THEY STILL

EFFECTIVE AND SAFE?

Made Ratna Saraswati

207

IS GLYCEMIC CONTROL STILL AT THE CORE OF T2D

MANAGEMENT IN THE ERA OF CV OUTCOME STUDIES?

Ketut Suastika

217

LONG TERM BENEFITS ON INTENSIVE GLUCOSE

CONTROL FOR PREVENTING END-STAGE KIDNEY

DISEASES

A. A. Budhiarta

227

ANEMIA IN CHRONIC KIDNEY DISEASE: HOW TO

REVEAL THE TRUE CAUSE?

I Gde Raka Widiana

(13)

xi

ANEMIA IN CHRONIC KIDNEY DISEASE: IS IT

ERYTHROPOETIN RESPONSIBILTY?

Yenny Kandarini

238

THROMBOEMBOLIC EVENT PREVENTION: WHICH

PATIENT AND WHEN?

Renny Anggreni Rena

246

THROMBOSIS: TO PREVENT OR TO THREAT? WHICH

DRUG?

I Wayan Losen Adnyana

253

RATE CONTROL FOR ATRIAL FIBRILATION

Adelia Yasmin

264

RHYTM CONTROL FOR ATRIAL FIBRILATION

I Made Putra Swi Antara

268

WORKSHOP

OVERVIEW: GENERAL CONSIDERATION OF LOCAL

INJECTION IN MUSCULOSKELETAL PROBLEM

Gede Kambayana

272

ROLE OF CORTICOSTEROID (TRIAMCINOLONE) IN

MUSCULOSKELETAL INJECTION

Pande Ketut Kurniari

280

ROLE OF ULTRASONOGRAPHY-GUIDED INJECTION IN

JOINT PAIN: PLANTAR FASCIITIS, KNEE, SHOULDER,

AND LOW BACK PAIN

Arif Soemarjono

288

OVERVIEW OF PLEURAL EFFUSION: ETIOLOGY,

DIAGNOSIS, AND TREATMENT

IGNB Artana

(14)

xii

MANAGEMENT OF PLEURAL EFFUSION USING MINI

WATER SEALED DRAINAGE (MINI WSD)

I Gede Ketut Sajinadiyasa

327

CLINICAL REASONING OF CONTINUOUS AMBULATORY

PERITONEAL DIALYSIS (CAPD)

Yenny Kandarini

332

TEHNIQUE OF CONTINUOUS AMBULATORY

PERITONEAL DIALYSIS (CAPD)

I Gusti Ngurah Agung Tresna Erawan

346

RECENT INFECTION COMPLICATION MANAGEMENT IN

PERITONEAL DIALYSIS PATIENTS

Nyoman Paramita Ayu

362

PRE TRAVEL PREVENTIVE CARE

Ni Made Dewi Dian Sukmawati

371

VACCINATION SAFETY AND VACCINE RELATED ADVERSE

REACTION

I Made Susila Utama

372

VACCINE HANDLING AND PREPARATION

Ni Made Dewi Dian Sukmawati

374

MANAGEMENT OF THYROID NODULE: MEDICAL

ASPECT PRE AND POST OPERATION

I Made Siswadi Semadi

375

FINE NEEDLE ASPIRATION BIOPSY (FNAB): METHOD

AND PATHOLOGY ANATOMY RESULT INTERPRETATION

Luh Putu Iin Indrayani Maker

381

(15)
(16)

xiv

JADWAL ACARA

SYMPOSIUM Day 1, Friday 2

nd

November 2018

Time Agenda 7.30 - 08.00 Registration 8.00 - 08.30 Opening: Ballroom

8.30 - 9.30 Moerdowo Memorial Lecture Supported by Pfizer

Controversies in Medicine: Challenges and Opportunities

Speaker: Prof. Dr. dr. I Made Bakta, SpPD, K-HOM

9.30 - 10.00 Coffee Break: Exhibition Room 10.00 - 11.00 Symposium debate 1

Nephrology and Hypertension Division Supported by: Novartis

Goal Oriented in Hypertension Venue: Ballroom

Symposium debate 2

Gastro Hepatology and Enterology Division

HBe Negative on Chronic Hepatitis B on Antiviral Therapy: Lifelong or Finite duration/Demand

Venue: Negara room 10.00 - 10.05 Brainstorming by moderator Dr. Jodi S. Loekman, SpPD, K-GH, FINASIM Brainstorming by moderator Dr. I Ketut Mariadi, SpPD, K-GEH, FINASIM 10.00 - 10.20 What’s New in Hypertension Guideline ESC/ESH 2018 and AACE 2017? Prof. Dr. dr. Ketut Suwitra, SpPD, K-GH,FINASIM Current Concepts in Chronic Hepatitis B Treatment Prof. Dr. dr. I D N Wibawa, SpPD, K-GEH, FINASIM 10.20 - 10.40 Goal Oriented in Hypertension: Under Control with Single Pill Combination: Amlodipine/Valsarta n Dr. dr. I Wayan Sudhana, SpPD, K-GH, FINASIM

Antiviral Therapy: Should It Be Lifelong? Dr. I G A Suryadharm a, SpPD, K-GEH, FINASIM

10.40 - 11.00 Discussion and wrap up Discussion and wrap up 11.00 - 12.00 Lunch Symposium 1

Nephrology and Hypertension Division join with Endocrinology and Metabolism Division Supported by: Boehringer Ingelheim

Oral Anti Diabetes in The Era of Cardiovascular Outcome Trial: Focus on Sodium Glucose Co- Transporter 2 Inhibitor (SGLT2i)

(17)

xv

Venue: Ballroom

11.00 - 11.05 Brainstorming by moderator dr. I Made Pande Dwipayana, SpPD, K-EMD, FINASIM

11.05 - 11.25 Role of kidney in glucose Homeostasis Prof. Dr. dr. I Gde Raka Widiana, SpPD, K-GH, FINASIM

11.25 - 11.45 Linking type 2 Diabetes Medication with cardiovascular outcome

Prof. Dr. dr. Ketut Suastika, SpPD, K-EMD, FINASIM

11.45 - 12.00 Discussion and wrap up 12.00 - 13.00 Lunch Break and Exhibition

13.00 - 14.00 Symposium debate 3 Pulmonary Division

Supported by: Prodia Laboratory Advance Diagnostic of Lung Tuberculosis Venue: Ballroom

Symposium debate 4 Geriatric Division Supported by: Fahrenheit Malnutrition in elderly Venue: Negara Room

13.00 - 13.05 Brainstorming by moderator dr. Putu Andrika, SpPD, K-IC, FINASIM Brainstorming by moderator dr. Nyoman Astika, SpPD, K-Ger, FINASIM 13.05 - 13.25 Diagnostic Modality for Lung Tuberculosis dr. I Made Bagiada, SpPD, K-P, FINASIM Controversion of pharmacologic therapy for anorexia in elderly Dr. dr. Tuty Kuswardhani, SpPD, K-Ger, MARS, FINASIM 13.25 - 13.45 Role of IGRA in Diagnosis of Lung Tuberculosis

Elva Aprilia Nasution, S.Farm

Choosing amino acids for treating sarcopenia in elderly: which one is better?

Dr. I Gusti Putu Suka Aryana, SpPD, K-Ger, FINASIM

13.45 - 14.00 Discussion and wrap up Discussion and wrap up 14.00 - 15.00 Symposium debate 5

Rheumatology Division

What is new Osteoarthritis Treatment

Symposium debate 6

Tropical and Infectious Disease Division Supported by: Fahrenheit

Corticosteroids and sepsis: do

corticosteroids reduce death or improved recovery in sepsis 14.00 - 14.05 Brainstorming by moderator dr. Pande Ketut Kurniari, SpPD, FINASIM Brainstorming by moderator dr. Ida Bagus Putrawan, SpPD, FINASIM 14.05 - 14.25 Overview of Ostoeoarthritis Prof. Dr. dr. Tjokorda Raka Putra, SpPD, K-R, FINASIM Corticosteroid harmful effects on sepsis Dr. dr. I Ketut Agus Somia, SpPD, K-PTI, FINASIM 14.25 - 14.45 Current Treatment of Osteoarthritis dr. Gde Kambayana, SpPD, K-R, FINASIM Corticosteroid beneficial effects dr. I Made Suslila Utama, SpPD,

(18)

K-xvi

on sepsis PTI, FINASIM

14.45 - 15.00 Discussion and wrap up Discussion and wrap up 15.00 - 16.00 Kompyang Memorial Lecture

Controversies in Medicine: How to Deal with Iron Deficient Anemia Properly

Speaker: Dr. dr. Ketut Suega, SpPD, K-HOM

Venue: Ballroom 16.00 - 17.00 Rehearsal

Preparation for Dinner Symposium 17.00 - 18.00 Dinner symposium (by invitation)

Endocrinology and Metabolism Division Supported by: PT. Merck Tbk

Diabetes and Thyroid: Old Friend

17.00 - 17.05 Brainstorming by moderator Dr. dr. Wira Gotera, SpPD, K-EMD, FINASIM

17.05 - 17.20 Management of Diabetes: Start with The Right Choice

Prof. DR. Dr. I Ketut Suastika, SpPD, K-EMD, FINASIM

17.20 - 17.35 Management of Hyperthyroidism Dr. dr. Made Ratna Saraswati, SpPD, K-EMD, FINASIM

17.35 - 17.50 Replacement Therapy in Hypothyroidism Dr. Risa Anwar

17.50 - 18.00 Discussion and wrap up

18.00 - 21.00 Dinner and Perdana Gathering Party 21.00 Closing

(19)

xvii

SYMPOSIUM Day 2, Saturday 2

nd

November 2018

Time Agenda 7.30 - 8.00 Registration 8.00 - 8.30 Special Case

8.00 - 8.05 Moderator: dr. Ketut Rai Purnami, SpPD

8.00 – 8.10 Special Case in Hepatology dr. Gede Somayana, SpPD

8.10 – 8.20 Special Case in Allergy and Immunology

dr. Vincentius Donnie Pramudita, SpPD

8.20 – 8.30 Discussion and wrap up 8.30 - 9.30 Symposium debate 7

Endocrinology and Metabolism Division

Supported by: Sanofi

Reaching Further Glycemic Control With Rapid Acting Insulin Analogues Venue: Ballroom

Symposium debate 8

Allergy and Immunology Division Drug Allergy

Venue: Negara room 8.30 - 8.35 Brainstorming by moderator dr. Made Pande Dwipayana, SpPD, K-EMD, FINASIM

Brainstorming by moderator dr. Tjokorda Istri Anom Saturti, SpPD, FINASIM 8.35 - 8.55 Insulin Therapy in The Diabetes Emergency: What's The Guideline Said To Improve Patient Outcome Prof. Dr. dr. Ketut Suastika, SpPD, K-EMD, FINASIM

Mechanism of Drug Allergy Dr. dr. Ketut Suryana, SpPD, K-AI, FINASIM

8.55 - 9.15 The Role of Rapid Insulin Analogue in Diabetes Management: Focus On Glulisine Clinical Evidence Dr. dr. Made Ratna Saraswati, SpPD, K-EMD, FINASIM

Diagnosis and Management of Drug Allergy

dr. Ketut Suardamana, SpPD, K-AI, FINASIM

9.15 - 9.30 Discussion and wrap up Discussion and wrap up 9.30 - 10.00 Coffee Break: Exhibition Room

10.00 - 11.00 Symposium debate 9

Endocrinology and Metabolism Division

Supported by: Aztra Zeneca Current and Future Challenging of Diabetes Type 2 Treatment Venue: Ballroom

Symposium debate 10

Endocrinology and Metabolism Division Supported by: Servier

Addresing the Challenges Beyond Diabetes Boundaries

Venue: Negara room

10.00-10.05 Brainstorming by moderator

Dr. dr. Wira Gotera, SpPD,

Brainstorming by moderator dr. Made Pande

(20)

xviii

K-EMD, FINASIM Dwipayana, SpPD, K-EMD, FINASIM 10.00-10.20 Current Diabetes Oral treatment: Are They still Effective and Safe? Dr. dr. Made Ratna Saraswati, SpPD, K-EMD, FINASIM

Is glycemic control still at the core of T2D management in the era of CV outcome studies?

Prof. Dr. dr. Ketut Suastika, SpPD, K-EMD, FINASIM 10.20-10.40 Are the innovative

Oral Therapy will replace current diabetes treatment? Dr. Putu Moda Arsana, SpPD, K-EMD,FINASIM

Long term benefits on intensive glucose control for preventing end-stage kidney diseases

Prof. Dr. dr. A. A. Budhiarta, SpPD, K-EMD, FINASIM 10.40-11.00 Discussion and wrap up Discussion and wrap up

11.00-12.00 Lunch Symposium 2

Nephrology and Hypertension Division Supported by: Etana

Anemia on Chronic Kidney Disease Venue: Ballroom

11.00-11.05 Brainstorming by moderator Dr. dr. Wayan Sudhana, SpPD, K-GH, FINASIM

11.05-11.25 Anemia in Chronic Kidney Disease: How to Reveal the True Cause?

Prof. Dr. dr. I Gde Raka Widiana, SpPD, K-GH

11.25-11.45 Anemia in Chronic Kidney Disease: Is It Erythropoetin Responsibilty?

Dr. dr. Yenny Kandarini, SpPD, K-GH, FINASIM

11.45-12.00 Discussion and wrap up 12.00-13.00 Lunch Break and Exhibition

13.00-14.00 Symposium debate 11

Hematology and Oncology Division Thrombosis: To Prevent or to Threat? Venue: Ballroom

Symposium debate 12 Cardiology Division

Management of Acute Presentation of Atrial Fibrilation

Venue: Negara Room 13.00-13.05 Brainstorming by moderator dr. Tjok Gde Darmayuda, SpPD, K-HOM, FINASIM

Brainstorming by moderator dr. Nyoman Wiryawan, SpJP

13.05-13.25 Thromboembolic Event Prevention: Which Patient and When?

dr. Reni Anggreni Rena, SpPD, K-HOM, FINASIM

Rate Control for Atrial Fibrilation dr. Adelia Yasmin, Sp.JP 13.25-13.45 Thrombosis: To Prevent or To Threat? Which Drug? dr. I Wayan Losen Adnyana, SpPD, K-HOM, FINASIM

Rhytm control for Atrial Fibrilation

dr. I Made Putra Swi Antara, SpJP (K), FIHA

(21)

xix

13.45-14.00 Discussion and wrap up Discussion and wrap up 14.00 - 15.00 Kaler Memorial Lecture

Controversies in Medicine: Diabetes is it genetic, metabolic, of lifestyle disorder

Speaker: Prof. Dr. dr. Dwi Sutanegara, SpPD, K-EMD, FINASIM

Venue: Ballroom 15.00 - 15.30 Closing

(22)

xx

SCHEDULE WORKSHOP, Thursday 1 November 2018

Angsoka Building level 4th Sanglah Hospital

Time Agenda

7.30-08.00 Registration for workshop 1, 2, and 3

8.00-08.30 Opening attend by all workshop participant (Venue: Meeting Room 1) 8.30-12.00 Workshop 1

Rheumatology Division

Pain Intervention in Musculoskeletal Problem Venue: Meeting Room 1

Workshop 2 Pulmonary Division

Management of Pleural Effusion Venue: Library Room 2

Workshop 3 Nephrology Division

Basic Continuous Ambulatory Peritoneal Dialysis (CAPD) Venue: Meeting Room 2

8.30-9.10 Overview: General Consideration of Local Injection in Musculoskeletal Problem dr. Gede Kambayana, SpPD, K-R,FINASIM 8.30-9.30 Overview of Pleural Effusion: Etiology, Diagnosis, and Treatment dr. IGNB Artana, SpPD

Clinical Reasoning of Continuous Ambulatory Peritoneal Dialysis (CAPD) Dr. dr. Yenny Kandarini, SpPD, K-GH, FINASIM 9.10-9.50 Role of Corticosteroid (Triamcinolone) in Musculoskeletal Injection dr. Pande Ketut Kurniari, SpPD, FINASIM Tehnique of Continuous Ambulatory Peritoneal Dialysis (CAPD)

dr. I Gusti Ngurah Agung Tresna Erawan, MBiomed, SpPD

9.50-10.30 Role of Ultrasonography-guided Injection in Joint Pain: Plantar Fasciitis, Knee, Shoulder, and Low Back Pain dr. Arif Soemarjono, SpKFR 9.30-10.30 Management of Pleural Effusion using Mini Water Sealed Drainage (Mini WSD) dr. I Gede Ketut Sajinadiyasa, SpPD, K-P, FINASIM

Recent Infection Complication Management in Peritoneal Dialysis Patients

dr. Nyoman Paramita Ayu, SpPD, K-GH

10.30-11.30 Hands on/Discussion Hands on/Discussion Hands on/Discussion 11.30-12.00 Wrap up and closing Wrap up and closing Wrap up and closing 12.00-13.00 Lunch break

(23)

xxi

12.30-13.00 Registration for workshop 4 and 5 13.00-16.30 Workshop 4

Tropical and Infectious Disease Division Vaccination and Travel medicine Venue: Meeting Room 1

Workshop 5

Endocrinology and Metabolism Division Management of Thyroid Nodule Venue: Library Room

13.00-13.40 Pre travel preventive care dr. Ni Made Dewi Dian Sukmawati, SpPD, FINASIM

Management of Thyroid Nodule: Medical Aspect Pre and Post Operation

Dr. I Made Siswadi Semadi, MBiomed, SpPD

13.40-14.20 How to tailored individual vaccination strategy

dr. A. A. A Yuli Gayatri, SpPD, K-PTI 14.20-15.00 Vaccination safety and vaccine

related adverse reaction

dr. I Made Susila Utama, SpPD, K-PTI, FINASIM

Fine Needle Aspiration Biopsy (FNAB): Method and Pathology Anatomy Result Interpretation

Dr. Luh Putu Iin Indrayani Maker, SpPA (K)

15.00-16.00 Hands on: Vaccine handling and preparation dr. Ni Made Dewi Dian, Sukmawati, SpPD

Hands on/Discussion

(24)

Pendidikan Kedokteran Berkelanjutan XXIV 2018

398

STUDI EPIDEMIOLOGI SARKOPENIA PADA ORANG USIA LANJUT DI

DESA PEDAWA, KECAMATAN BANJAR, BULELENG

Nadia Pramita Dewi

1

, IGP Suka Aryana

2

, Wayan Giri Putra Semaradana

1

,

RA Tuty Kuswardhani

2

, I Nyoman Astika

2

, IB Putrawan

2

, Rai Purnami

2

1

PPDS-1 Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Udayana

2

Divisi Geriatri, Departemen/KSM Penyakit Dalam, FK UNUD/RSUP Sanglah,

Denpasar, Bali

Latar Belakang

Penuaan berdampak pada perubahan struktur tubuh, yaitu seperti hilangnya

secara progresif massa otot, perlambatan pergerakan otot, dan juga penurunan

kekuatan otot. Fenomena ini diperkenalkan oleh Rosenberg pada tahun 1989

sebagai sarkopenia (Yunani) yang merupakan singkatan dari “sarco-“ atau otot

dan “-penia” yang mengindikasikan defisiensi otot. Definisi terbaru kemudian

dipublikasikan oleh European Working Group on Sarcopenia in Older People

(EWGSOP) pada tahun 2010 yang memasukkan perubahan fungsi otot atau

kelemahan otot yang menyertai berkurangnya massa otot. Sarkopenia telah

dilaporkan berhubungan secara bermakna dengan impairment fungsional dan

disabilitas pada lanjut usia (lansia) yang akan berdampak pada kualitas hidup

dan selanjutnya kemampuan bertahan hidup sehingga menjadi hal yang

penting untuk diperhatikan agar dapat dilakukan langkah-langkah pencegahan

dan antisipasif.

1

Sarkopenia merupakan suatu sindrom yang ditandai oleh kehilangan

progresif massa otot dan kekuatan otot. Sarkopenia umumnya diiringi

inaktivitas fisik, penurunan mobilitas, cara berjalan yang lambat, dan endurans

fisik yang rendah. Studi menunjukkan bahwa setelah usia 50 tahun massa otot

menurun sekitar 1-2% per tahun, sedangkan kekuatan otot menurun sekitar

1,5% per tahun antara usia 50-60 tahun, dan semakin turun hingga 3% per

tahun setelah usia 60 tahun. penurunan massa otot ini ditemukan tinggi pada

individu dengan gaya hidup sedentary dan meningkat dua kali lipat pada pria

dibandingkan wanita.

2

Tidak ada konsensus definisi sarkopenia dan bervariasinya kriteria

diagnostik (nilai normatif untuk cut-off point parameter sarkopenia)

menyebabkan prevalensi sarkopenia bervariasi pada berbagai macam

penelitian kohort dengan rentang 7–50% pada lansia. Pada tahun 2009

EWGSOP mempublikasikan definisi klinis dan kriteria diagnostik untuk

(25)

Referensi

Dokumen terkait

• Penularan terjadi melalui gigitan, cakaran, kontak langsung dengan darah, cairan tubuh atau lesi di kulit atau mukosa hewan dan makan daging yang tidak dimasak dengan baik.. •

Pada sekitar 20-50% individu dengan asma, obstruksi saluran nafas terkait latihan fisik ini juga dapat diamati beberapa jam setelah latihan fisik.. Hal ini

Jadi pemeriksaan anti dsDNA memiliki dua kegunaan klinis penting yaitu pertama untuk diagnosis (titer tinggi anti dsDNA memiliki spesifisitas lebih dari 90% pada SLE),

Pada tahun 2009, IASLC mengusulkan bagan baru dari kelenjar getah bening regional, dikelompokkan dalam zona dan stasiun yang harus dipertimbangkan dengan

Tube) untuk identifikasi Mycobacterium tuberkulosis (M.tb). Pemeriksaan tersebut diatas dilakukan disarana laboratorium yang terpantau mutunya. Dalam menjamin hasil

Asma berhubungan dengan hiperresponsivitas saluran udara akibat rangsangan langsung atau tidak langsung, serta berhubungan dengan inflamasi jalan nafas kronik. Kedua